Use fundamental data analysis to confirm all available indicators of Therapix Biosciences to find out if markets are presently mispricing the corporation. We found sixteen available drivers for Therapix Biosciences Ltd which can be compared to its competition. Use Therapix Biosciences Net Income, Book Value Per Share, Beta, as well as the relationship between Cash per Share and Earnings Per Share to make sure your decision on pricing Therapix Biosciences is adequate. Use Therapix Biosciences to enhance returns of your portfolios. The stock experiences unexpected upward trend. Watch out for market signals. Check odds of Therapix Biosciences to be traded at 40.44 in 30 days
Therapix Biosciences Company Summary
Therapix Biosciences competes with Bank Leumi, Perrigo Company, Israel Chemicals, NICE Ltd, and Azrieli Group. Therapix Biosciences Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Therapix Biosciences Ltd. was founded in 2004 and is headquartered in Givatayim, Israel. Therapix Biosciences operates under Biotechnology classification in Israel and traded on Tel Aviv Stock Exchange. It employs 9 people.
Therapix Biosciences Earnings Per Share vs Cash per Share
Therapix Biosciences Ltd is rated below average in earnings per share category among related companies. It is rated below average in cash per share category among related companies .
|Earnings Per Share ( times )|
Therapix Biosciences Market Fundamentals